indomethacin has been researched along with Coxsackie Virus Infections in 4 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Indomethacin has been shown to increase virus titers and to worsen cardiac injury in the acute phase of coxsackievirus B4 murine myocarditis." | 7.68 | Focal ventricular thinning caused by indomethacin in the late phase of coxsackievirus B4 murine myocarditis. ( Khatib, G; Khatib, R; Kloner, RA; Reyes, MP; Rezkella, S; Smith, F, 1992) |
| "Previous studies have shown that indomethacin administered during the early phase of experimental myocarditis may exacerbate the disease process." | 7.67 | Effect of indomethacin in the late phase of coxsackievirus myocarditis in a murine model. ( Khatib, G; Khatib, R; Kloner, R; Rezkalla, S; Smith, F; Sowers, J; Walsh, M, 1988) |
| "Indomethacin has been shown to increase virus titers and to worsen cardiac injury in the acute phase of coxsackievirus B4 murine myocarditis." | 3.68 | Focal ventricular thinning caused by indomethacin in the late phase of coxsackievirus B4 murine myocarditis. ( Khatib, G; Khatib, R; Kloner, RA; Reyes, MP; Rezkella, S; Smith, F, 1992) |
| "The effect of salicylates or indomethacin usage during viral infection was investigated in a murine model of coxsackievirus B3 myocarditis." | 3.67 | Coxsackievirus B3 murine myocarditis: deleterious effects of nonsteroidal anti-inflammatory agents. ( Khatib, G; Khatib, R; Rezkalla, S, 1986) |
| "Previous studies have shown that indomethacin administered during the early phase of experimental myocarditis may exacerbate the disease process." | 3.67 | Effect of indomethacin in the late phase of coxsackievirus myocarditis in a murine model. ( Khatib, G; Khatib, R; Kloner, R; Rezkalla, S; Smith, F; Sowers, J; Walsh, M, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khatib, R | 4 |
| Reyes, MP | 2 |
| Khatib, G | 4 |
| Smith, F | 3 |
| Rezkella, S | 1 |
| Kloner, RA | 1 |
| Rezkalla, S | 3 |
| Walsh, M | 1 |
| Sowers, J | 1 |
| Kloner, R | 1 |
4 other studies available for indomethacin and Coxsackie Virus Infections
| Article | Year |
|---|---|
Focal ventricular thinning caused by indomethacin in the late phase of coxsackievirus B4 murine myocarditis.
Topics: Animals; Coxsackievirus Infections; Enterovirus B, Human; Heart; Indomethacin; Mice; Myocarditis; My | 1992 |
Enhancement of coxsackievirus B4 virulence by indomethacin.
Topics: Animals; Antibodies, Viral; Coxsackievirus Infections; Disease Models, Animal; Enterovirus B, Human; | 1990 |
Coxsackievirus B3 murine myocarditis: deleterious effects of nonsteroidal anti-inflammatory agents.
Topics: Animals; Antibodies, Viral; Coxsackievirus Infections; Indomethacin; Interferons; Mice; Myocarditis; | 1986 |
Effect of indomethacin in the late phase of coxsackievirus myocarditis in a murine model.
Topics: Animals; Atrial Natriuretic Factor; Chronic Disease; Coxsackievirus Infections; Disease Models, Anim | 1988 |